Innovent Biologics (1801.HK) — market event timeline

NashNova tracks 2 market events mentioning Innovent Biologics (1801.HK) between 2026-06-24 and 2026-06-29, each with a dated one-line analysis of how the event relates to the asset.

  1. HK Stocks Midday: Hang Seng Up 2.12%, Innovative Drug Index Surges 8.9% to Lead Gains

    Dual medical-commercial insurance catalog negotiations directly benefit innovative drug leaders; Innovent Biologics up 7% with strong liquidity.

  2. Eli Lilly's Oral GLP-1 Drug Orforglipron Could Launch in China by Late 2026 at the Earliest

    A leading domestic GLP-1 pipeline player — Lilly's oral drug entry into China intensifies competition and directly affects its weight-loss pipeline commercialization prospects.

For research and information only — not investment advice.

Innovent Biologics (1801.HK) — News & AI Analysis · NashNova